Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

June 4, 2018

Study Completion Date

June 18, 2018

Conditions
Acute Coronary Syndrome
Interventions
DRUG

D578

D578 Tab.1T single oral administration under fasting condition

DRUG

CKD-357

CKD-357 Tab.1T single oral administration under fasting condition

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY